Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tigecycline vs Vancomycin + Aztreonam in cSSSI
NCT00228410Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2002
- Primary completion
- Dec 2003
- Modality
- Orthosteric Ligands
01
Overview
A Phase 3 trial of tigecycline in Skin and Skin Structure Infection (SSSI), sponsored by Pfizer. Started Nov 2002; status: completed.
02
Drugs
tigecycline
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00228410.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00228410.